ANVS - Annovis Bio, Inc. Common Stock

Annovis Bio, Inc. (ANVS)

AMEX · Common · CUSIP 03615A108

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ANVS and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 03615A108
Market Cap: Small Cap
IPO: 1/29/2020 · $6.00/share

Links: Home Page Investor Relations News

Business: Annovis Bio, Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS).

Company Contact

CEO: Maria Maccecchini
CFO: Henry Hagopian
Headquarters: 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312
Phone: 610-727-3913
Investor Relations: Maria L. Maccecchini · 610-727-3710 · maccecchini@annovisbio.com
General Email: info@annovisbio.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »